Tandem Diabetes Care, Inc. (TNDM) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
51/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseTNDM / S&P -21.28% / 15.20% |
LoseTNDM / S&P 3.96% / 15.00% |
LoseTNDM / S&P -70.23% / 50.40% |
| 2026-Q10/3 |
LoseTNDM / S&P -12.78% / -4.33% |
LoseTNDM / S&P 4.54% / 11.30% |
LoseTNDM / S&P -50.00% / 27.70% |
| 2025-Q42/3 |
WinTNDM / S&P 81.05% / 2.65% |
LoseTNDM / S&P 7.93% / 9.00% |
WinTNDM / S&P 109.59% / 13.40% |
| 2025-Q32/3 |
LoseTNDM / S&P -34.87% / 8.12% |
WinTNDM / S&P 17.87% / 4.61% |
WinTNDM / S&P 58.03% / 13.45% |
| 2025-Q22/3 |
LoseTNDM / S&P -2.71% / 10.94% |
WinTNDM / S&P 25.84% / 4.83% |
WinTNDM / S&P 47.85% / 10.63% |
| 2025-Q12/3 |
LoseTNDM / S&P -46.81% / -4.27% |
WinTNDM / S&P 27.65% / 4.98% |
WinTNDM / S&P 28.11% / 10.57% |
| 2024-Q41/3 |
LoseTNDM / S&P -15.07% / 2.41% |
WinTNDM / S&P 25.74% / 5.25% |
LoseTNDM / S&P -57.56% / 6.15% |
| 2024-Q31/3 |
LoseTNDM / S&P 5.26% / 5.89% |
WinTNDM / S&P 10.75% / 5.89% |
LoseTNDM / S&P -40.06% / 6.11% |
| 2024-Q21/3 |
WinTNDM / S&P 13.78% / 4.28% |
LoseTNDM / S&P 0.72% / 5.38% |
LoseTNDM / S&P -39.77% / 5.12% |
| 2024-Q11/3 |
WinTNDM / S&P 19.71% / 10.56% |
LoseTNDM / S&P -3.11% / 5.71% |
LoseTNDM / S&P -31.33% / 5.59% |
| 2023-Q42/3 |
WinTNDM / S&P 42.42% / 11.69% |
LoseTNDM / S&P -6.68% / 6.81% |
WinTNDM / S&P 134.01% / 7.78% |
| 2023-Q31/3 |
LoseTNDM / S&P -15.36% / -3.27% |
LoseTNDM / S&P -2.44% / 7.52% |
WinTNDM / S&P 203.77% / -5.03% |
| 2023-Q21/3 |
LoseTNDM / S&P -39.57% / 8.74% |
LoseTNDM / S&P 3.21% / 9.50% |
WinTNDM / S&P 1552.38% / -8.57% |
| 2023-Q10/3 |
LoseTNDM / S&P -9.66% / 7.50% |
LoseTNDM / S&P 7.73% / 10.77% |
LoseTNDM / S&P -3611.11% / -15.69% |
| 2022-Q41/3 |
LoseTNDM / S&P -6.06% / 7.56% |
WinTNDM / S&P 14.00% / 11.88% |
LoseTNDM / S&P -712.50% / -17.99% |
| 2022-Q31/3 |
LoseTNDM / S&P -19.16% / -4.88% |
WinTNDM / S&P 19.65% / 13.47% |
LoseTNDM / S&P -394.44% / -1.41% |
| 2022-Q21/3 |
LoseTNDM / S&P -49.10% / -16.10% |
WinTNDM / S&P 26.61% / 13.71% |
LoseTNDM / S&P -275.00% / 11.04% |
| 2022-Q11/3 |
LoseTNDM / S&P -22.74% / -4.60% |
WinTNDM / S&P 36.12% / 15.97% |
LoseTNDM / S&P -123.08% / 42.23% |
| 2021-Q42/3 |
WinTNDM / S&P 26.08% / 11.03% |
WinTNDM / S&P 40.89% / 15.00% |
LoseTNDM / S&P TNDM unavailable / 96.40% |
| 2021-Q32/3 |
WinTNDM / S&P 22.57% / 0.58% |
WinTNDM / S&P 50.48% / 10.77% |
LoseTNDM / S&P TNDM unavailable / 69.42% |
| 2021-Q22/3 |
WinTNDM / S&P 10.37% / 8.55% |
WinTNDM / S&P 47.44% / 6.58% |
LoseTNDM / S&P TNDM unavailable / 51.81% |
| 2021-Q11/3 |
LoseTNDM / S&P -7.77% / 6.17% |
WinTNDM / S&P 37.47% / -1.06% |
LoseTNDM / S&P TNDM unavailable / 7.39% |
| 2020-Q41/3 |
LoseTNDM / S&P -15.70% / 12.15% |
WinTNDM / S&P 37.68% / -3.72% |
LoseTNDM / S&P TNDM unavailable / -33.42% |
| 2020-Q32/3 |
WinTNDM / S&P 14.74% / 8.93% |
WinTNDM / S&P 33.04% / -2.04% |
LoseTNDM / S&P TNDM unavailable / -27.10% |
| 2020-Q22/3 |
WinTNDM / S&P 53.72% / 20.54% |
WinTNDM / S&P 45.62% / -0.46% |
LoseTNDM / S&P TNDM unavailable / -27.11% |
| 2020-Q12/3 |
WinTNDM / S&P 7.95% / -19.60% |
WinTNDM / S&P 77.12% / 3.47% |
LoseTNDM / S&P TNDM unavailable / -14.75% |
| 2019-Q41/3 |
LoseTNDM / S&P 1.07% / 9.07% |
WinTNDM / S&P 97.05% / 5.36% |
LoseTNDM / S&P TNDM unavailable / 2.99% |
| 2019-Q31/3 |
LoseTNDM / S&P -8.59% / 1.70% |
WinTNDM / S&P 123.10% / 5.02% |
LoseTNDM / S&P TNDM unavailable / 0.21% |
| 2019-Q21/3 |
LoseTNDM / S&P 1.61% / 4.30% |
WinTNDM / S&P 118.89% / 6.64% |
LoseTNDM / S&P TNDM unavailable / 8.65% |
| 2019-Q12/3 |
WinTNDM / S&P 67.24% / 13.65% |
WinTNDM / S&P 92.05% / 8.12% |
LoseTNDM / S&P TNDM unavailable / 14.29% |
| 2018-Q42/3 |
WinTNDM / S&P -11.37% / -13.52% |
WinTNDM / S&P 70.88% / 9.05% |
LoseTNDM / S&P TNDM unavailable / 18.23% |
| 2018-Q32/3 |
WinTNDM / S&P 94.55% / 7.71% |
WinTNDM / S&P 53.78% / 10.21% |
LoseTNDM / S&P TNDM unavailable / 19.06% |
| 2018-Q22/3 |
WinTNDM / S&P 343.95% / 3.43% |
WinTNDM / S&P 57.90% / 9.03% |
LoseTNDM / S&P TNDM unavailable / 14.46% |
| 2018-Q12/3 |
WinTNDM / S&P 110.17% / -0.76% |
WinTNDM / S&P 39.36% / 7.68% |
LoseTNDM / S&P TNDM unavailable / 12.46% |
| 2017-Q41/3 |
LoseTNDM / S&P -67.67% / 6.64% |
WinTNDM / S&P 27.72% / 7.03% |
LoseTNDM / S&P TNDM unavailable / 13.82% |
| 2017-Q31/3 |
LoseTNDM / S&P -8.75% / 4.48% |
WinTNDM / S&P 13.93% / 5.68% |
LoseTNDM / S&P TNDM unavailable / 17.57% |
| 2017-Q20/3 |
LoseTNDM / S&P -33.33% / 3.09% |
LoseTNDM / S&P -7.25% / 4.83% |
LoseTNDM / S&P TNDM unavailable / 17.74% |
| 2017-Q10/3 |
LoseTNDM / S&P -44.19% / 6.07% |
LoseTNDM / S&P 3.18% / 3.67% |
LoseTNDM / S&P TNDM unavailable / 13.32% |
| 2016-Q41/3 |
LoseTNDM / S&P -71.93% / 3.82% |
WinTNDM / S&P 15.65% / 2.09% |
LoseTNDM / S&P TNDM unavailable / 7.05% |
| 2016-Q31/3 |
LoseTNDM / S&P 1.59% / 3.85% |
WinTNDM / S&P 37.06% / 0.20% |
LoseTNDM / S&P TNDM unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | TNDM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 71.06% | 20.78% |
| Annualized return | 71.06% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | TNDM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -81.30% | 83.14% |
| Annualized return | -28.49% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | TNDM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -69.69% | 319.30% |
| Annualized return | -11.25% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |